Endologix (ELGX) Announces First Patients Treated with Ovation Alto™ Abdominal Stent Graft System
Endologix, Inc. (NASDAQ: ELGX) is one of the best known developers and marketers of unique treatments for aortic disorders. The company recently announced that the first two patients with abdominal aortic aneurysms (AAA) were treated with the Ovation Alto™ Abdominal Stent Graft System in Auckland, New Zealand. Andrew Hill, MD, and Andrew Holden, MD, of Auckland City Hospital treated the two patients. Ovation Alto is part of the abdominal graft systems. The device was introduced to the market very recently and has been added to the Ovation® platform. Patients with complicated AAAs have been added to the Ovation Alto, expanding…